Increased DNA Synthetic Potency of Hepatocytes in Cirrhotic Patients May Indicate a Super-High Risk for Hepatocellular Carcinoma

Bromodeoxyuridine (BrdU) labeling indices (LI) of liver biopsied specimens from 27 control liver cirrhosis patients (control LC) without hepatocellular carcinoma (HCC), 26 cirrhotic patients with HCC, and from 6 control subjects were examined using an in vitro BrdU labeling technique. The mean BrdU...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese Journal of Medicine 1990, Vol.29(4), pp.373-378
Hauptverfasser: TARAO, Kazuo, SHIMIZU, Akio, HARADA, Masaoki, OHKAWA, Shinichi, TAMAI, Setsuo, ITO, Yoshihiko, KUNI, Yukifusa, TAKEMIYA, Shoji, OKAMOTO, Takashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bromodeoxyuridine (BrdU) labeling indices (LI) of liver biopsied specimens from 27 control liver cirrhosis patients (control LC) without hepatocellular carcinoma (HCC), 26 cirrhotic patients with HCC, and from 6 control subjects were examined using an in vitro BrdU labeling technique. The mean BrdU LI±S.E. of HCC cancerous portion, HCC non-cancerous cirrhotic portion, control LC, and control subjects were 6.6±0.8%, 2.7±0.3%, 1.7±0.3% and 0.25±0.09%, respectively. Interestingly, there was a significant difference (p
ISSN:0021-5120
1881-123X
DOI:10.2169/internalmedicine1962.29.373